| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Alimera Sciences, Inc.: Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 40 | GlobeNewswire (Europe) | ATLANTA, June 04, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera" or the "Company"), a global pharmaceutical company whose mission is to be invaluable to patients, physicians... ► Artikel lesen | |
| 14.05. | ALIMERA SCIENCES INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.05. | ALIMERA SCIENCES INC - 8-K, Current Report | 1 | SEC Filings | ||
| 29.04. | ALIMERA SCIENCES INC - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 19.03. | Alimera Sciences, Inc.: Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network | 472 | GlobeNewswire (Europe) | ATLANTA, March 19, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners... ► Artikel lesen | |
| 08.03. | ALIMERA SCIENCES INC - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 08.03. | ALIMERA SCIENCES INC - 10-K, Annual Report | 1 | SEC Filings | ||
| 07.03. | Alimera Sciences Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 07.03. | ALIMERA SCIENCES INC - 8-K, Current Report | 1 | SEC Filings | ||
| 07.03. | Alimera Sciences, Inc.: Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results | 141 | GlobeNewswire (Europe) | Q4 Net Revenues up 88% to $26.3 million vs. Q4 20222023 Net Revenues up 49% to $80.8 million vs. 2022Increases 2024 Revenue Guidance ATLANTA, March 07, 2024 (GLOBE NEWSWIRE) -- Alimera... ► Artikel lesen | |
| 09.02. | ALIMERA SCIENCES INC - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 09.02. | ALIMERA SCIENCES INC - 8-K, Current Report | - | SEC Filings | ||
| 08.02. | Alimera Sciences, Inc.: The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN® | 2 | GlobeNewswire (USA) | ||
| 04.01. | ALIMERA SCIENCES INC - 8-K, Current Report | 1 | SEC Filings | ||
| 02.01. | Alimera Sciences, Inc.: Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 181 | GlobeNewswire (Europe) | ATLANTA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera" or the "Company"), a global pharmaceutical company whose mission is to be invaluable to patients, physicians... ► Artikel lesen | |
| 12.12.23 | ALIMERA SCIENCES INC - 8-K, Current Report | 1 | SEC Filings | ||
| 12.12.23 | Alimera Sciences, Inc.: Alimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 344 | GlobeNewswire (Europe) | ATLANTA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera" or the "Company"), a global pharmaceutical company whose mission is to be invaluable to patients, physicians... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TUI | 3.812 |
| NVIDIA | 2.651 |
| GAMESTOP | 2.142 |
| NEL | 1.918 |
| BAYER | 1.745 |
| EVOTEC | 1.624 |
| PLUG POWER | 1.610 |
| BYD | 1.129 |
| SUPER MICRO COMPUTER | 765 |
| VOLKSWAGEN | 764 |
| DEUTSCHE LUFTHANSA | 683 |
| RHEINMETALL | 677 |
| BIONTECH | 619 |
| AIXTRON SE | 597 |
| ALLIANZ | 500 |
| DEUTSCHE TELEKOM | 495 |
| BASF | 492 |
| OMV | 485 |
| PALANTIR TECHNOLOGIES | 485 |
| THYSSENKRUPP | 482 |
| NOVAVAX | 478 |
| TESLA | 478 |
| DEUTSCHE BANK | 463 |
| SIEMENS ENERGY | 459 |
| RWE | 448 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
